CD59 and Miyoshi myopathy: In addition, we reveal that MM PB and BM EV CD147, and complement inhibitory molecules CD55 and CD59 levels may have diagnostic and prognostic value, whereas EV PD-L1 levels may indicate response to DARA therapy.